N/A
Completed N=87,665
From Innovation to Solutions: Childhood Influenza Vaccination Planning
Source: ClinicalTrials.gov NCT01664793 ↗Enrolled (actual)
87,665
Serious AEs
0.0%
Results posted
Nov 2014
Primary outcomePrimary: Primary Outcome — 26432; 19352 participants vaccinated out of all — p=<0.05
Summary
The purpose of this study is to increase childhood influenza vaccination rates using the FDA licensed influenza vaccines according to national guidelines in a randomized cluster trial in which primary care offices are randomized to intervention or control with the control group receiving the intervention in the second year.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Primary Outcome |
26432; 19352 | <0.05 sig |
| SECONDARY Effectiveness Score |
75 | — |
Eligibility Criteria
Inclusion criteria
For children: attendance at the selected health care center within the last year and age >/=6 months thru 18 years.
Exclusion Criteria
For children: Severe egg allergy or allergy to influenza vaccine
Data sourced from ClinicalTrials.gov (NCT01664793). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.